BEHANDLING AF TUMORER UNDER ANVENDELSE AF SPECIFIKT ANTI-L1-ANTISTOF

The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.

Saved in:
Bibliographic Details
Main Authors MÖBIUS, ULRICH, BREITLING, FRANK, LÜTTGAU, SANDRA, BÄRREITER, SILKE, SEBENS, SUSANNE, KRÜGER, ACHIM, KELM, DANIELA, ALTEVOGT, PETER, MOLDENHAUER, GERHARD, LI, YI, SCHÄFER, HEINER
Format Patent
LanguageDanish
Published 02.02.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
Bibliography:Application Number: DK20080759230T